IDH1 and glioma: Mellinghoff Mellinghoff IK IK Penas-Prado Penas-Prado M M Peters Peters KB KB Vorasidenib, a dual inhibitor of mutant IDH1/2, in recurrent or progressive glioma; results of a first-in-human phase I trial Vorasidenib, a dual inhibitor of mutant IDH1/2, in recurrent or progressive glioma; results of a first-in-human phase I trial Clin Cancer Res Clin Cancer Res 2021 2021 27 27 16 16 4491 4491 4499 4499 10.1158/1078-0432.CCR-21-0611 10.1158/1078-0432.CCR-21-0611 supplied-pmid 34078652?